Clinical Trials Browser

INDUSTRY × Triple Negative Breast Neoplasms × veliparib × Clear all

NCT03123211 2022-05-24

Expanded Access to Veliparib

No longer available

Triple Negative Breast Neoplasms

NCT02032277 2021-01-20

A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

Phase 3 Completed

Neoplasms, Triple Negative Breast Neoplasms